Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT02279394. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma
ClinicalTrials.gov study NCT02416206. IPD Sharing: Not stated. Countries: 1. Publications: 26.
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT05706766. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02514668. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
ClinicalTrials.gov study NCT03525678. IPD Sharing: YES. Countries: 8. Publications: 8.
A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT02541383. IPD Sharing: Not stated. Countries: 3. Publications: 9.
Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01645930. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02004275. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03029234. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01818752. IPD Sharing: Not stated. Countries: 30. Publications: 3.
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01324947. IPD Sharing: Not stated. Countries: 15. Publications: 3.
Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients
ClinicalTrials.gov study NCT01568866. IPD Sharing: Not stated. Countries: 27. Publications: 21.
Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)
ClinicalTrials.gov study NCT02906332. IPD Sharing: NO. Countries: 1. Publications: 57.
A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00478777. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00552396. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04798586. IPD Sharing: NO. Countries: 1. Publications: 3.
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
ClinicalTrials.gov study NCT00531284. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04892446. IPD Sharing: NO. Countries: 3. Publications: 2.
A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03312530. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00378105. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.